Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans
Authors
Keywords
Adiponectin, Obesity, Cytokines, Insulin, Adipose tissue, Fats, Fibroblast growth factor, Fatty acids
Journal
PLoS One
Volume 8, Issue 10, Pages e78864
Publisher
Public Library of Science (PLoS)
Online
2013-10-19
DOI
10.1371/journal.pone.0078864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
- (2013) K. M. Habegger et al. DIABETES
- Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes
- (2013) Yang Xiao et al. PLoS One
- Structure, Signalling and Physiologic Role of Adiponectin-Dietary and Exercise- Related Variations
- (2012) I. J. Hickman et al. CURRENT MEDICINAL CHEMISTRY
- PAI-1 and Diabetes: A Journey From the Bench to the Bedside
- (2012) D. J. Schneider et al. DIABETES CARE
- Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls
- (2012) Sara G Vienberg et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes
- (2012) Kwok Leung Ong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
- (2012) Huating Li et al. JOURNAL OF HEPATOLOGY
- Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans
- (2012) Dorit Samocha-Bonet et al. PLoS One
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance
- (2011) Lucy S. Jun et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
- (2011) Ingrid C. Gaemers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
- (2011) H. Yu et al. CLINICAL CHEMISTRY
- Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers
- (2011) Birgitte Andersen et al. CLINICAL ENDOCRINOLOGY
- Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome
- (2011) Ekaterini Koiou et al. GYNECOLOGICAL ENDOCRINOLOGY
- Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?
- (2011) Takashi Uebanso et al. PLoS One
- Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
- (2010) Knut Mai et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in Humans
- (2010) C. S. Tam et al. DIABETES
- Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice
- (2010) H. Guo et al. DIABETES
- Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity
- (2010) I. K.M. Law et al. DIABETES
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- A family history of type 2 diabetes increases risk factors associated with overfeeding
- (2010) D. Samocha-Bonet et al. DIABETOLOGIA
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Relation between fibroblast growth factor–21, adiposity, metabolism, and weight reduction
- (2010) Knut Mai et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease
- (2009) Kerry-Lee Milner et al. HEPATOLOGY
- Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men
- (2009) Charlotte Brøns et al. JOURNAL OF PHYSIOLOGY-LONDON
- Differential Effect of Weight Loss on Adipocyte Size Subfractions in Patients With Type 2 Diabetes
- (2009) Magdalena Pasarica et al. Obesity
- The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man
- (2008) Cecilia Gälman et al. Cell Metabolism
- Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women
- (2008) K. M. Choi et al. CLINICAL ENDOCRINOLOGY
- Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
- (2008) Leonie Heilbronn et al. CURRENT PHARMACEUTICAL DESIGN
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fatty Liver
- (2007) Anna Kotronen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now